Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Encavis AG

Start price
Target price
Perf. (%)
€15.10
27.07.21
€17.00
27.07.22
3.84%
07.08.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
Overstock.com

Start price
Target price
Perf. (%)
€68.78
27.07.21
-
27.07.22
-14.16%
23.08.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
buy
Infineon Technologies AG

Start price
Target price
Perf. (%)
€32.03
27.07.21
-
27.07.22
4.14%
20.08.21

Could be worthwhile Investment >10% per year
buy
Infineon Technologies AG

Start price
Target price
Perf. (%)
€32.03
27.07.21
-
27.07.22
4.14%
20.08.21

Could be worthwhile Investment >10% per year
buy
SGL Carbon SE

Start price
Target price
Perf. (%)
€9.36
27.07.21
-
27.07.22
11.32%
03.09.21

Could be worthwhile Investment >10% per year
buy
Tencent Holdings Ltd.

Start price
Target price
Perf. (%)
€49.81
27.07.21
-
27.07.22
-21.36%
13.03.22

buy
Tencent Holdings Ltd.

Start price
Target price
Perf. (%)
€49.81
27.07.21
-
27.07.22
-21.36%
13.03.22

buy
Harvard Bioscience

Start price
Target price
Perf. (%)
€6.50
27.07.21
-
27.07.22
-25.54%
02.03.22

buy
2U Inc.

Start price
Target price
Perf. (%)
€36.89
27.07.21
-
27.07.22
-73.49%
27.07.22

buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€228.70
26.07.21
€243.00
26.07.22
-3.59%
26.07.22

High dividend yield expected
Good rating
Could be worthwhile Investment >10% per year
Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.32
26.07.21
-
26.07.22
-48.82%
27.07.22

Risky Investment
buy
SAF Holland SE

Start price
Target price
Perf. (%)
€11.39
26.07.21
€12.50
26.07.22
-40.56%
26.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
buy
Dynatronics Corp

Start price
Target price
Perf. (%)
€1.07
26.07.21
€2.50
26.07.22
-1.87%
07.08.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
buy
Socket Mobile Inc.

Start price
Target price
Perf. (%)
€6.40
26.07.21
-
26.07.22
-15.00%
07.08.21

Could be worthwhile Investment >10% per year
Fair valuation
Bad rating
Few uniques
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€1.66
26.07.21
-
26.07.22
-21.08%
27.07.22

Could be very worthwhile Investment >20% year
buy
Mind Technology Inc.

Start price
Target price
Perf. (%)
€1.75
26.07.21
-
26.07.22
-56.29%
27.07.22

Could be very worthwhile Investment >20% year
buy
Shimano Inc

Start price
Target price
Perf. (%)
€218.80
25.07.21
€240.00
25.07.22
-22.30%
26.07.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
Shimano Inc

Start price
Target price
Perf. (%)
€218.80
25.07.21
€240.00
25.07.22
-22.30%
26.07.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
Shimano Inc

Start price
Target price
Perf. (%)
€218.80
25.07.21
€240.00
25.07.22
-22.30%
26.07.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
Shimano Inc

Start price
Target price
Perf. (%)
€218.80
25.07.21
€240.00
25.07.22
-22.30%
26.07.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
Meta Material Inc.

Start price
Target price
Perf. (%)
€3.08
25.07.21
-
25.07.22
-69.75%
26.07.22

Could be worthwhile Investment >10% per year
Moderna Inc.

Start price
Target price
Perf. (%)
€299.00
24.07.21
€111.00
24.07.22
-45.65%
25.07.22

Sustainability is little important
Higher risks for its business
Probably not worthwhile Investment
Charles Schwab Corp.

Start price
Target price
Perf. (%)
€57.70
23.07.21
-
23.07.22
15.23%
04.06.22

negative Cash Flow expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.00
23.07.21
-
23.07.22
-84.43%
24.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Standard Investments for future growth
High valuation
buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€70.24
23.07.21
-
23.07.22
34.45%
13.03.22